Tina K. Runk, M.B.A.
Co-founder, EVP Clinical Operations & Director
Ms. Runk has over 35 years of experience in research, preclinical & clinical development and operations, working with biopharmaceutical companies and CROs in the US and around the world, such as Oread, ILEX Oncology (Genzyme), PSI & Ergomed.
Fatih M. Uckun, M.D., Ph.D
EVP, Global Head of Clinical and Medical Affairs; CSO
Fatih M. Uckun, M.D., Ph.D., is an Active Member of the American Society for Clinical Investigation (ASCI), an honor society for physician-scientists, and an active member of several professional organizations, including ASCO and AACR.
Safwan Kezbor, M.D.
Medical Director Clinical Development
Accomplished strategic thinker research physician and medical monitor with extensive experience in the global pharmaceutical industry in multiple therapeutic areas. Over a decade of clinical research and drug development experience in the pharmaceutical industry, CRO, and academia.
Narayan Lebaka
Senior Director of Clinical Data Management
Highly motivated, astute, and results-driven self-starter with exceptional organizational, analytical, and clinical data management skills. B.S. and ten 15 + years of award-winning and progressive experience delivering the highest standards of clinical data management at Bayer and Bristol Myers Squibb (BMS).
David Jackson, M.D., MBA
Senior Medical Director, Neurology
David joined Triplet Therapeutics, Inc. as Senior Medical Director, Neurology in April 2021. Dr. Jackson will perform a key role in providing medical expertise and direction in global clinical drug development strategy and planning with a focus on neurodegenerative repeat expansion disorders.
Earle T. Holsapple
President & Co-Founder
Earle has successfully served as CEO/COO of six profitable midsize companies. He developed and raised the initial funding for the SoftVueTM technology for Karmanos Cancer Institute, It is a novel breast cancer detection product now in clinical trials with Delphinus Medical Technologies, Inc.
